Effect of Quetiapine in the Treatment of Panic Attacks in Patients with Schizophrenia: 3 Case Reports

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 16, Issue 1, 2004, Pages 113-115

  Takahashi, Hitoshi ^a   Sugita, Takio ^a   Yoshida, Keizo ^a   Higuchi, Hisashi ^a   Shimizu, Tetsuo ^a  

^a AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; BROMPERIDOL; DOPAMINE; FLUVOXAMINE; HALOPERIDOL; NEUROLEPTIC AGENT; QUETIAPINE; RISPERIDONE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; DOSE RESPONSE; DRUG EFFECT; FEMALE; HUMAN; MALE; MENTAL PATIENT; PANIC; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; SCHIZOPHRENIA; TREATMENT OUTCOME;

EID: 1242352516     PISSN: 08950172     EISSN: None     Source Type: Journal    
DOI: 10.1176/jnp.16.1.113     Document Type: Article

References (15)

1. Boyd JH: Use of mental health services for the treatment of panic disorder. Am J Psychiatry 1986; 143:1569-1574
2. Kasper S, Resinger E: Panic disorder: the place of benzodiazepines and selective serotonin reuptake inhibitors. Eur Neuropsychopharmacol 2001; 11:307-321
3. Kahn JP, Puertollano MA, Schane MD, et al: Adjunctive alprazolam for schizophrenia with panic anxiety: clinical observation and pathogenetic implications. Am J Psychiatry 1988; 145:742-744
4. Marder SR, Davis JM, Chouinard G: The effects of risperidone on the five dimensions of schizophrenia derived by factor analysis: combined results of the North American trials. J Clin Psychiatry 1997; 58:538-546
5. Tollefson GD, Sanger TM: Anxious-depressive symptoms in schizophrenia: a new treatment target for pharmacotherapy? Schizophr Res 1999; 35 Suppl:13-21
6. Takahashi H, Higuchi H, Shimizu T: Full remission of panic attacks in a schizophrenic patient after switching from haloperidol to risperidone. J Neuropsychiatry Clin Neurosci 2001; 13:113-114
7. Etxebeste M, Aragues E, Malo P, et al: Olanzapine and panic attacks. Am J Psychiatry 2000; 157:659-660
8. Chamey DS, Heninger GR, Breier A: Noradrenergic function in panic anxiety. Effects of yohimbine in healthy subjects and patients with agoraphobia and panic disorder. Arch Gen Psychiatry 1984; 41:751-763
9. Iruela LM, Ibanez-Rojo V, Oliveros SC, et al: Panic attacks in schizophrenia. Br J Psychiatry 1991; 158:436-437
10. Argyle N: Panic attacks in chronic schizophrenia. Br J Psychiatry 1990; 157:430-433
11. Higuchi H, Kamata M, Yoshimoto M, et al: Panic attacks in patients with chronic schizophrenia: a complication of long-term neuroleptic treatment. Psychiatry Clin Neurosci 1999; 53:91-94
12. Vazquez A, Jimenez-Jimenez FJ, Garcia-Ruiz P, et al: "Panic attacks" in Parkinson's disease. A long-term complication of levodopa therapy. Acta Neurol Scand 1993; 87:14-18
13. Remington G, Kapur S: D2 and 5-HT2 receptor effects of anti-psychotics: bridging basic and clinical findings using PET. J Clin Psychiatry 1999; 60 Suppl 10:15-19
14. Kapur S, Zipursky RB, Remington G: Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia. Am J Psychiatry 1999; 156:286-293
15. Bressan RA, Monteiro VB, Dias CC: Panic disorder associated with clozapine. Am J Psychiatry 2000; 157:2056